Pharma Focus Asia

Nephron Pharmaceuticals Corporation Invests US$215m in New Projects in Lexington County


Nephron Pharmaceuticals Corporation has announced major investment plan in Lexington County, where it is headquartered, with an investment of US$215 million.


An investment of more than US$215 million includes an addition of new office, warehouse and vaccine production space in the county’s Saxe-Gotha Industrial Park.

The new project will be an addition to Nephron’s existing US$313 million investment which has generated more than 1,800 full and part time jobs over a five-year period.

This investment also includes building warehouse and vaccine production space, creating 380 new full-time jobs. The company expects the facility to be operational in 2024.


NameNephron Pharmaceuticals Corporation
TypeNew construction
Budget$215 million
magazine-slider-imageHexagon - Expert Insights WebinarMFA + MMA 20244th Annual Cleaning Validation 20242nd Annual Pharma Impurity Conclave 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference